PML/RAR alpha + ATRA = CR. A comment on acute promyelocytic leukaemia: molecular pathology and treatment.
Dyer
M J
MJ
Haddow Laboratories, Royal Marsden Hospital, Sutton, Surrey, U.K.
D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy / Q000235:genetics*; D018168:Receptors, Retinoic Acid / Q000235:genetics*; D012074:Remission Induction; D000072482:Retinoic Acid Receptor alpha; D014178:Translocation, Genetic; D014212:Tretinoin / Q000627:therapeutic use*
C000607071:RARA protein, human; D018168:Receptors, Retinoic Acid; D000072482:Retinoic Acid Receptor alpha; D014212:Tretinoin